Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsola is a veterinary nutritional supplement developed and marketed by Navana Pharmaceuticals. It is formulated as an oral liquid solution containing a combination of calcium, phosphorus, vitamin D3 (cholecalciferol), and vitamin B12 (cyanocobalamin). Capsola is indicated for livestock (such as cattle, buffalo, horses, calves, sheep, and goats) to prevent and treat deficiency syndromes of these essential minerals and vitamins. It is used to support bone and teeth formation, improve fertility, stimulate immunity, and enhance milk production and body weight gain. It is also effective in managing conditions like milk fever, rickets, osteomalacia, anemia, infertility, and anorexia in livestock.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Capsola.